Δ
Race Oncology CEO/MD Phil Lynch speaks to Matt Birney of the Bulls n’ Bears Report about Race’s latest results and outlook.
https://youtu.be/XCrwvbUZiWM
The Board of Directors of Race Oncology wishes to advise that Dr. Peter Molloy has…
MST Access has initiated coverage of Race Oncology with a current $4.88 per share valuation.…